Board Meeting Details

The Board of Directors of Vineet Laboratories Limited held a meeting on Monday, 26th October 2026 at 5.30 P.M. at the company's registered office. The meeting commenced at 5.30 P.M. (IST) and concluded at 6.25 P.M. (IST).

Items Approved

1. Unaudited financial results for the quarter ended 30.06.2026

2. Limited Review Report for the quarter ended 30.06.2026

Financial Results Summary (Quarter ended June 30, 2026)

Income Statement (Amounts in INR Lakh)

  • Net Sales/Income from operations: ₹1,039.32
  • Total Income from operations: ₹1,039.32
  • Other income: ₹10.80
  • Total Income: ₹1,050.12

Expenses Breakdown

  • Cost of materials consumed: ₹1,000.13
  • Changes in inventories: ₹(386.64) decrease
  • Employee benefits expenses: ₹133.81
  • Finance cost: ₹96.93
  • Depreciation and amortization expenses: ₹60.37
  • Other expenses: ₹66.95
  • Total expenses: ₹971.56

Profitability Metrics

  • Profit before exceptional items and tax: ₹85.56
  • Profit before tax: ₹85.56
  • Tax expense: ₹(72.86) [Deferred tax net]
  • Profit for the period: ₹151.43
  • Other comprehensive income: ₹0.00
  • Total comprehensive income: ₹151.43

Comparative Performance

Vs. Previous Quarter (March 31, 2026 - Audited):

  • Total Income decreased from ₹1,892.12 lakh to ₹1,050.12 lakh
  • Profit before tax decreased from ₹99.46 lakh to ₹85.56 lakh
  • Net profit decreased from ₹72.51 lakh to ₹151.43 lakh

Vs. Year-ago Quarter (June 30, 2025 - Unaudited):

  • Total Income increased from ₹745.99 lakh to ₹1,050.12 lakh
  • Turnaround from loss of ₹(90.16) lakh to profit of ₹151.43 lakh

Capital Structure

  • Paid Up Equity Share Capital: ₹1,920.63 lakh (Face Value of ₹10/- each)
  • Other equity: Not specified for current quarter

Earnings Per Share (not annualized)

  • Basic EPS: ₹0.73
  • Diluted EPS: ₹0.73

Auditor's Review

NSVR & Associates LLP, Chartered Accountants (FRN: 0088015/5200060), conducted a limited review of the unaudited financial results pursuant to Regulation 33 of SEBI LODR Regulations, 2015. Partner V Gangadhara Rao N (Membership No: 219486) issued an unqualified report stating that nothing came to their attention suggesting material misstatement. The review was conducted in accordance with SRE 2410 standards and provides moderate assurance.

Additional Notes

1. Financial results prepared in accordance with Indian Accounting Standards (Ind AS)

2. Company operates in one reportable business segment: Active Pharmaceuticals Ingredient and intermediates

3. Segmental reporting as per Ind AS 108 not applicable

4. Figures for previous periods rearranged/reclassified for consistency

5. Quarter ended March 31, 2026 figures are balancing figures between audited annual figures and limited reviewed YTD figures

6. New Labour Codes implementation assessment: Company states it is already compliant with basic wages criteria and expects no material impact